What should you know about immunotherapy and melanoma?

Some medicines release immune brakes that melanoma cells can exploit. The activated immune response may then target melanoma cells in the skin or elsewhere. Treatment may be discussed after surgery, for melanoma that cannot be removed locally, or when it has spread, depending on the clinical picture.

The team considers the melanoma’s depth and spread, biopsy and scan findings, previous treatment, and illnesses that could make immune inflammation more difficult to manage. A changing skin lesion, scan finding, or symptom is interpreted in that wider context.

Before treatment, share your history of autoimmune disease, organ problems, transplant, allergies, medicines, and supplements. Ask how infusions or other doses are scheduled and which tests will be used to monitor you. Keep the oncology contact details available at home.

Immune effects can involve the skin, bowel, lungs, liver, kidneys, nerves, or hormone glands. Record new diarrhoea, rash, cough, headache, weakness, visual change, or marked tiredness and report it rather than self-treating for several days.

Contact the treatment team promptly for a spreading rash, persistent diarrhoea, new cough or breathlessness, yellow skin, reduced urine, severe headache, confusion, visual changes, or sudden weakness. Seek emergency care for severe breathing difficulty, fainting, or sudden neurological symptoms.

Where is the melanoma and what does the staging assessment show? Is immunotherapy being considered before or after surgery, or because the melanoma has spread? Which immune side effects are urgent? How will scans and examinations show whether the plan is helping?